Navigation Links


specificity at Biology News

Unique dual target specificity of kinase inhibitor key for success against cancer

Scientists have identified a new molecule that inhibits proliferation of a broad range of lethal malignant glioma cells in vitro and in vivo. The findings, published in the May issue of Cancer Cell, shed light on which PI3 kinase family members are most likely to play a role in cancer progression. This study reinforces the concept that successful small molecule kinase inhibitors must display a br...
specificity at Biology Products
specificity at Biology Technology

Greater Amplification Specificity with New Hot Start PCR Enzyme

Taq DNA polymerase makes hot start simple and efficient Jonathan Eads Frances Bai Ronda Allen Holly Hogrefe <p align="...

Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer

transgenicrodent mutation assay Centre for Environmental Health, University of Victoria, Victoria, BC Canada transgenic rodent mutationassay,* which carries the E. coli lacI transgene in a retrievabl...

Improve Amplification Specificity with Hot Start PCR Enzyme

Taq2000 features a modified version of Taq2000 with hot start capability. Using SureStart Taq, hot start is in- corporated into PCR protocols previously optimized with Taq DNA...
specificity at Medicine News
specificity at Medicine Products
specificity at Medicine Technology
Other TagsChicagoChicagoCompanyCompanyCompanyCompanyLucigenLucigenBiomedicalBiomedicalMirusMirusBrandingFiservAuroraPatentPatent
(Date:7/25/2008)... The Retina Group of New York will present a...r degeneration especially designed for seniors. Th...ibrary at 116 Merritts Road, Farmingdale, NY 11735...ce is free and refreshments will be provided. The ...0. , Hicksville and Haupp...
(Date:7/25/2008)... The Drug Information Association (DIA) and ...he Critical Path Initiative (CPI) on the Move: Com...da, MD) and the Critical Path Transporter Workshop... Horsham, PA (PRWEB) July 25, 2005-- T...ociation (DIA)] and the Food and Drug Administrati...
(Date:7/25/2008)... Columbus-based law firm represents Pickerin...urchased at Columbus-area Kroger store , ...25, 2008 -- http://www.donaheyohioinjurylawyers.c...sonal injury law firms in central Ohio, has filed ...rt (Case No. 08CV9804) against The Kroger Co., in ...
(Date:7/24/2008)... Hoag to lease hospital facility on Sand Can...h, CA (Vocus) July 24, 2008 -- Hoag Memorial Hospi..., Inc. (NYSE: HCP), a Real Estate Investment Trust...-bed hospital facility on Sand Canyon Avenue near ...lity is currently operated by Tenet Healthcare Cor...
Breaking Medicine News(10 mins):Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2
(Date:7/24/2008)... , July 24, 2008 A new study by researchers from...alth addresses one of the most challenging issues ...V transmission in poor countries. In these settin... the best outcome for their infants, they should e...g four to six months after birth. But according to...
(Date:7/24/2008)... , Irvine, Calif. UC Irvine researchers have f...ur own body clock and metabolism. The discovery r...etes, obesity and other related diseases. , Paol... of Pharmacology, and his colleagues have identifi...ulates the body,s circadian rhythms, works in bala...
(Date:7/24/2008)... , PORTLAND, Ore. July 23, 2008. A fire is curren... were made about fire behavior about 2 years ago. ...ate-Successional Reserve (LSR) study in the planni...r where the Cold Springs fire is now active., Th...de Range in Washington, and covers about 15,000 ac...
(Date:7/23/2008)... , COLUMBUS, Ohio Wealthy nations willing to col...event the emission of roughly half a billion metri...years, new research suggests. , It would take a...he tropical deforestation in the world, one of the...earchers estimate. , If adopted, this type of pr...
Breaking Biology News(10 mins):Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2Landscape study may offer solutions for fire managers 2Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4Free White Paper Available for Clinical Laboratory Managers 3A Effectively Isolating Anaerobic Bacteria 2686 1Free White Paper Available for Clinical Laboratory Managers 3A Effectively Isolating Anaerobic Bacteria 2686 2Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 1Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 2Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 3iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 1iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 2iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 3iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 4Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 1Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 2Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 3Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 4
Other Contentsrepulsionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresponseresponseresponseresponseresponseresponseresponseresponseresponseresponseresponsivenessresponsivenessresponsivenessresponsivenessresponsivenessrestingrestingrestingrestingrestingrestingrestingrestingenzymesenzymesenzymesenzymesenzymesenzymesenzymesenzymeslysatelysatereticulocytereticulocyte